Status:
UNKNOWN
Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
Else Kröner Fresenius Foundation
AIT Austrian Institute of Technology GmbH
Conditions:
End Stage Renal Disease
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the use of non-invasive markers of the autonomic function and micro- and macrocirculation to predict mortality and cardiovascular end points in end-stage renal...
Eligibility Criteria
Inclusion
- Age 18 or older
- End-stage renal disease (ESRD) and receiving maintenance hemodialysis
Exclusion
- Any clinically significant infection.
- pregnancy
- history of malignant disease with a prognostic life expectancy less than 24 months
- missing of written and informed consent
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01152892
Start Date
April 1 2010
End Date
May 1 2020
Last Update
January 26 2016
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
KFH Dialysis Center
Altötting, Bavaria, Germany, 84503
2
KFH Dialysis Center Dillingen
Dillingen an der Donau, Bavaria, Germany, 89407
3
Praxen Dr. Braun Dingolfing
Dingolfing, Bavaria, Germany, 84130
4
KFH Dialysis Center Elsenheimerstrasse
Munich, Bavaria, Germany, 80687